Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Clinical trials have shown that it has the potential to cause weight loss in non-diabetic obese individuals ( 3.2 Longacting GLP1 receptor agonists: once-daily 3.2.1 Lixisenatide LIXI is a once-daily GLP-1R agonist
Side Effects and Additional Safety Information Semaglutide (Wegovy), tirzepatide (Zepbound), orforglipron (Foundayo), liraglutide (Saxenda) 1-4 Contraindications: Personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known serious hypersensitivity to any of the ingredients in the product Warnings and Precautions: Thyroid C-cell tumors have occurred in animal studies
Cardiovascular Fitness Optimizing endurance for fat-burning efficiency
